312 related articles for article (PubMed ID: 9715666)
1. Interaction of amelogenin with hydroxyapatite crystals: an adherence effect through amelogenin molecular self-association.
Moradian-Oldak J; Tan J; Fincham AG
Biopolymers; 1998 Oct; 46(4):225-38. PubMed ID: 9715666
[TBL] [Abstract][Full Text] [Related]
2. Interactions of amelogenins with octacalcium phosphate crystal faces are dose dependent.
Iijima M; Moradian-Oldak J
Calcif Tissue Int; 2004 Jun; 74(6):522-31. PubMed ID: 15354860
[TBL] [Abstract][Full Text] [Related]
3. Modification of calcium-phosphate coatings on titanium by recombinant amelogenin.
Wen HB; Moradian-Oldak J
J Biomed Mater Res A; 2003 Mar; 64(3):483-90. PubMed ID: 12579562
[TBL] [Abstract][Full Text] [Related]
4. Analysis of hydroxyapatite surface coverage by amelogenin nanospheres following the Langmuir model for protein adsorption.
Bouropoulos N; Moradian-Oldak J
Calcif Tissue Int; 2003 May; 72(5):599-603. PubMed ID: 12704567
[TBL] [Abstract][Full Text] [Related]
5. Control of apatite crystal growth in a fluoride containing amelogenin-rich matrix.
Iijima M; Moradian-Oldak J
Biomaterials; 2005 May; 26(13):1595-603. PubMed ID: 15522761
[TBL] [Abstract][Full Text] [Related]
6. Self-assembly of a recombinant amelogenin protein generates supramolecular structures.
Fincham AG; Moradian-Oldak J; Simmer JP; Sarte P; Lau EC; Diekwisch T; Slavkin HC
J Struct Biol; 1994; 112(2):103-9. PubMed ID: 8060728
[TBL] [Abstract][Full Text] [Related]
7. Assembly of amelogenin proteolytic products and control of octacalcium phosphate crystal morphology.
Moradian-Oldak J; Iijima M; Bouropoulos N; Wen HB
Connect Tissue Res; 2003; 44 Suppl 1():58-64. PubMed ID: 12952175
[TBL] [Abstract][Full Text] [Related]
8. The effect of recombinant mouse amelogenins on the formation and organization of hydroxyapatite crystals in vitro.
Beniash E; Simmer JP; Margolis HC
J Struct Biol; 2005 Feb; 149(2):182-90. PubMed ID: 15681234
[TBL] [Abstract][Full Text] [Related]
9. Control of apatite crystal growth by the co-operative effect of a recombinant porcine amelogenin and fluoride.
Iijima M; Du C; Abbott C; Doi Y; Moradian-Oldak J
Eur J Oral Sci; 2006 May; 114 Suppl 1():304-7; discussion 327-9, 382. PubMed ID: 16674703
[TBL] [Abstract][Full Text] [Related]
10. Self-assembly and effect on crystal growth of the leucine-rich amelogenin peptide.
Habelitz S; DenBesten PK; Marshall SJ; Marshall GW; Li W
Eur J Oral Sci; 2006 May; 114 Suppl 1():315-9; discussion 327-9, 382. PubMed ID: 16674705
[TBL] [Abstract][Full Text] [Related]
11. The onset of amelogenin nanosphere aggregation studied by small-angle X-ray scattering and dynamic light scattering.
Aichmayer B; Margolis HC; Sigel R; Yamakoshi Y; Simmer JP; Fratzl P
J Struct Biol; 2005 Sep; 151(3):239-49. PubMed ID: 16125972
[TBL] [Abstract][Full Text] [Related]
12. Self-assembly properties of recombinant engineered amelogenin proteins analyzed by dynamic light scattering and atomic force microscopy.
Moradian-Oldak J; Paine ML; Lei YP; Fincham AG; Snead ML
J Struct Biol; 2000 Jul; 131(1):27-37. PubMed ID: 10945967
[TBL] [Abstract][Full Text] [Related]
13. Elongated growth of octacalcium phosphate crystals in recombinant amelogenin gels under controlled ionic flow.
Iijima M; Moriwaki Y; Wen HB; Fincham AG; Moradian-Oldak J
J Dent Res; 2002 Jan; 81(1):69-73. PubMed ID: 11820371
[TBL] [Abstract][Full Text] [Related]
14. Analysis of self-assembly and apatite binding properties of amelogenin proteins lacking the hydrophilic C-terminal.
Moradian-Oldak J; Bouropoulos N; Wang L; Gharakhanian N
Matrix Biol; 2002 Mar; 21(2):197-205. PubMed ID: 11852235
[TBL] [Abstract][Full Text] [Related]
15. Controlled proteolysis of amelogenins reveals exposure of both carboxy- and amino-terminal regions.
Moradian-Oldak J; Jimenez I; Maltby D; Fincham AG
Biopolymers; 2001 Jun; 58(7):606-16. PubMed ID: 11285557
[TBL] [Abstract][Full Text] [Related]
16. Supramolecular assembly of amelogenin nanospheres into birefringent microribbons.
Du C; Falini G; Fermani S; Abbott C; Moradian-Oldak J
Science; 2005 Mar; 307(5714):1450-4. PubMed ID: 15746422
[TBL] [Abstract][Full Text] [Related]
17. Enamel structure properties controlled by engineered proteins in transgenic mice.
Fong H; White SN; Paine ML; Luo W; Snead ML; Sarikaya M
J Bone Miner Res; 2003 Nov; 18(11):2052-9. PubMed ID: 14606519
[TBL] [Abstract][Full Text] [Related]
18. Dynamic light scattering study of an amelogenin gel-like matrix in vitro.
Petta V; Moradian-Oldak J; Yannopoulos SN; Bouropoulos N
Eur J Oral Sci; 2006 May; 114 Suppl 1():308-14; discussion 327-9, 382. PubMed ID: 16674704
[TBL] [Abstract][Full Text] [Related]
19. Amelogenin supra-molecular assembly in vitro compared with the architecture of the forming enamel matrix.
Moradian-Oldak J; Goldberg M
Cells Tissues Organs; 2005; 181(3-4):202-18. PubMed ID: 16612086
[TBL] [Abstract][Full Text] [Related]
20. The pH dependent amelogenin solubility and its biological significance.
Tan J; Leung W; Moradian-Oldak J; Zeichner-David M; Fincham AG
Connect Tissue Res; 1998; 38(1-4):215-21; discussion 241-6. PubMed ID: 11063029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
